S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PCSA Processa Pharmaceuticals Inc

0.238

-0.0009 (-0.38%)

26 Apr 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals Inc News

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
Tuesday 15 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 12 April 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 12 April 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 21 March 2025 (1 month ago) • Edgar (US Regulatory)

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Tuesday 18 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 19 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 February 2025 (2 months ago) • Edgar (US Regulatory)

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
Saturday 8 February 2025 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 31 January 2025 (3 months ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Friday 31 January 2025 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (3 months ago) • Edgar (US Regulatory)

More Processa Pharmaceuticals Inc News Articles

Verizon Communications

Westpac Banking

Newcrest Mining

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions